Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE

User menu

  • Log out
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log out
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE
PreviousNext
Articles

A heparan sulfate proteoglycan in developing avian axonal tracts

W Halfter
Journal of Neuroscience 1 July 1993, 13 (7) 2863-2873; https://doi.org/10.1523/JNEUROSCI.13-07-02863.1993
W Halfter
Department of Neurobiology, University of Pittsburgh, Pennsylvania 15261.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

A neuronal heparan sulfate proteoglycan was identified by a panel of four monoclonal antibodies. The antibodies were generated from mice immunized with embryonic chick retina basal lamina (clones 3A12, 3A3, and 9E10) and embryonic chick optic tract (clone 6D2). Cross-reactivity of all four antibodies with the purified proteoglycan confirmed that the antibodies were directed to the same antigen. Antibodies to heparan sulfate proteoglycan from embryonic chick muscle or EHS mouse tumor (perlecan) did not cross-react with the neuronal heparan sulfate proteoglycan, suggesting that the two proteoglycans are not related. In Western blots, the proteoglycan had a molecular weight of 600 kDa that dropped to 250 kDa when the samples were treated with heparitinase or nitric acid. Immunocytochemistry showed that in early stages of chick and quail development, the proteoglycan was exclusively localized in basal laminae and had a distribution similar to that of laminin. During further development, a strong labeling was also found in the extracellular environment of nerve tracts, such as the optic nerve and white matter areas of the brain and spinal cord. The labeling of axonal tracts declined from embryonic day 10 onward, while labeling in basal laminae persisted. Antibodies to muscle heparan sulfate proteoglycan or to perlecan did not label nerve fibers. The data show that embryonic neuronal tissue expresses a new type of heparan sulfate proteoglycan.

Back to top

In this issue

The Journal of Neuroscience: 13 (7)
Journal of Neuroscience
Vol. 13, Issue 7
1 Jul 1993
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
A heparan sulfate proteoglycan in developing avian axonal tracts
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
View Full Page PDF
Citation Tools
A heparan sulfate proteoglycan in developing avian axonal tracts
W Halfter
Journal of Neuroscience 1 July 1993, 13 (7) 2863-2873; DOI: 10.1523/JNEUROSCI.13-07-02863.1993

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
A heparan sulfate proteoglycan in developing avian axonal tracts
W Halfter
Journal of Neuroscience 1 July 1993, 13 (7) 2863-2873; DOI: 10.1523/JNEUROSCI.13-07-02863.1993
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

  • Memory Retrieval Has a Dynamic Influence on the Maintenance Mechanisms That Are Sensitive to ζ-Inhibitory Peptide (ZIP)
  • Neurophysiological Evidence for a Cortical Contribution to the Wakefulness-Related Drive to Breathe Explaining Hypocapnia-Resistant Ventilation in Humans
  • Monomeric Alpha-Synuclein Exerts a Physiological Role on Brain ATP Synthase
Show more Articles
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Accessibility
(JNeurosci logo)
(SfN logo)

Copyright © 2025 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.